Join CBSET and CILcare at ACT 2019, the 40th Annual Meeting of the American College of Toxicology and Council, November 17–20, 2019, at the JW Marriott Desert Ridge in Phoenix, Arizona.
The 40th Annual Meeting will include a wide-ranging scientific program, a welcome reception, the popular traditional poster session reception, an awards ceremony and luncheon, distinguished plenary speakers, and numerous professional networking events.
CBSET’s Director of Business Development, Michael Naimark, and Aurore Marie, Engineer, R&D Senior Project Manager and IMPLAN-T Project Director at CILcare, will be presenting a poster on the topic “Development of large animal models of trans-tympanic injection into the middle ear and ototoxicity.”
If you would like to meet up with us there, please contact us.
Related Services and Publications:
- CBSET GLP Preclinical Services
- GLP Preclinical Services for Auditory Safety
- Localized / Targeted Drug Delivery
Stem Cell and Regenerative Therapies for Hearing Loss
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare
World Pharma Today, Volume 3, Issue April, 2018
Auditory Therapy, Ototoxicity, and GLP Compliance: Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve?by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare
Published in World Pharma Today, November 1, 2017